Bay Street News, 2025

TEL-AVIV, Israel, March 31, 2025 (GLOBE NEWSWIRE) — Ellomay Capital Ltd. (NYSE American; TASE: ELLO) (“Ellomay” or the “Company”), a […]

Lead candidate ARD-101 demonstrated clinical activity and was generally well tolerated in a two-part Phase 2 trial in Prader-Willi Syndrome […]

Mick Hitchcock, Ph.D., appointed Interim Chief Executive Officer Biomea preparing icovamenib for late-stage clinical development Multiple milestones anticipated in 2025 […]

JACKSONVILLE, Fla., March 31, 2025 (GLOBE NEWSWIRE) — FRP Holdings, Inc. (NASDAQ: FRPH) announced today several updates regarding its investor […]

Announced demonstrated ability to deliver transient gene therapy (payload) to tumors using systemic antitumor virotherapy platform Filed IND in March […]

CLAYMONT, Del., March 31, 2025 (GLOBE NEWSWIRE) — Archimedes Tech SPAC Partners II Co. (Nasdaq: ATIIU) (the “Company”) today announced […]

– Infrastructure: DBM Global fourth quarter revenue of $225.7 million –– Life Sciences: MediBeacon®Transdermal GFR (“TGFR”) system received FDA approval […]

SAN FRANCISCO, March 31, 2025 (GLOBE NEWSWIRE) — American Shared Hospital Services (NYSE American: AMS) (the “Company”), a leading provider […]

HOUSTON, March 31, 2025 (GLOBE NEWSWIRE) — Kirby Corporation (“Kirby”) (NYSE: KEX) will announce its 2025 first quarter results at […]

ATLANTA, March 31, 2025 (GLOBE NEWSWIRE) — Gray Media, Inc. (“Gray” or the “Company”) (NYSE: GTN) today announced that it […]